RedHill Biopharma announced that it has received approval from the Listing Qualifications Department of The Nasdaq Stock Market to transfer the listing of the American Depositary Shares to the Nasdaq Capital Market. The ADSs will be transferred to the Nasdaq Capital Market at the opening of business on November 15. Trading of RedHill ADSs will be unaffected by the transfer, with no break in trading, and will continue under the same ticker symbol of “RDHL” and utilizing the existing CUSIP number.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RDHL: